07:00 , May 26, 2014 |  BC Week In Review  |  Clinical News

Architect Stat High Sensitive Troponin-I Assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland) and the Architect Stat High Sensitive Troponin-I assay from Abbott for the early rule...
07:00 , May 26, 2014 |  BC Week In Review  |  Clinical News

Access AccuTnl+3 troponin I assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland) and the Architect Stat High Sensitive Troponin-I assay from Abbott Laboratories (NYSE:ABT,...
07:00 , May 26, 2014 |  BC Week In Review  |  Clinical News

Elecsys Troponin T high-sensitive assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche and the Architect Stat High Sensitive Troponin-I assay from Abbott Laboratories (NYSE:ABT, Abbott Park, Ill.) for the early...
07:00 , Oct 7, 2013 |  BC Week In Review  |  Clinical News

Access AccuTnl+3 troponin I assay regulatory update

Danaher's Beckman Coulter Inc. subsidiary said FDA granted 510(k) clearance for its Access AccuTnl+3 troponin I assay for use on its UniCel DxI series of immunoassay systems to determine levels of cardiac troponin I...
07:00 , Jun 24, 2013 |  BC Week In Review  |  Clinical News

Access AccuTnl+3 troponin I assay regulatory update

Danaher's Beckman Coulter Inc. subsidiary said FDA granted 510(k) clearance for its Access AccuTnl+3 troponin I assay for use on its Access 2 immunoassay system to determine levels of cardiac troponin I in human...